AU5475900A - A method to improve protective immunity induced by polynucleotide vaccines - Google Patents
A method to improve protective immunity induced by polynucleotide vaccinesInfo
- Publication number
- AU5475900A AU5475900A AU54759/00A AU5475900A AU5475900A AU 5475900 A AU5475900 A AU 5475900A AU 54759/00 A AU54759/00 A AU 54759/00A AU 5475900 A AU5475900 A AU 5475900A AU 5475900 A AU5475900 A AU 5475900A
- Authority
- AU
- Australia
- Prior art keywords
- protective immunity
- immunity induced
- polynucleotide vaccines
- improve protective
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 title 1
- 230000036039 immunity Effects 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13860399P | 1999-06-11 | 1999-06-11 | |
US60138603 | 1999-06-11 | ||
PCT/US2000/015839 WO2000076539A2 (en) | 1999-06-11 | 2000-06-09 | A method to improve protective immunity induced by polynucleotide vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5475900A true AU5475900A (en) | 2001-01-02 |
Family
ID=22482776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54759/00A Abandoned AU5475900A (en) | 1999-06-11 | 2000-06-09 | A method to improve protective immunity induced by polynucleotide vaccines |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1225914A2 (en) |
AU (1) | AU5475900A (en) |
WO (1) | WO2000076539A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1583500A4 (en) * | 2002-11-13 | 2008-02-13 | Us Navy | Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
CA2563538C (en) * | 2004-04-28 | 2013-12-17 | The Trustees Of The University Of Pennsylvania | Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6210663B1 (en) * | 1998-08-20 | 2001-04-03 | The Wistar Institute Of Anatomy And Biology | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
-
2000
- 2000-06-09 AU AU54759/00A patent/AU5475900A/en not_active Abandoned
- 2000-06-09 WO PCT/US2000/015839 patent/WO2000076539A2/en not_active Application Discontinuation
- 2000-06-09 EP EP00939712A patent/EP1225914A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000076539A2 (en) | 2000-12-21 |
WO2000076539A3 (en) | 2001-05-03 |
EP1225914A2 (en) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145044A0 (en) | Vaccine | |
AU2002313425A1 (en) | Method to activate a vending machine | |
GB0024434D0 (en) | Speed control method | |
AU6094500A (en) | A method for improving interrupt response time | |
HUP0203335A3 (en) | Vaccine | |
SG87089A1 (en) | Process to fabricate a novel source-drain extension | |
AU5475900A (en) | A method to improve protective immunity induced by polynucleotide vaccines | |
GB9902557D0 (en) | Improvements to improve a danbouy | |
AU6604701A (en) | Method to induce the TH1 immune response | |
GB9913327D0 (en) | Vaccine | |
GB2349891B (en) | Recovery method | |
AU6884600A (en) | Method to fabricate a mosfet | |
AU2001287716A1 (en) | Method for preparing a vitroceramic hob and vitroceramic hob produced according to said method | |
WO2004095475A3 (en) | Control line protector | |
TW366824U (en) | Strike practicing machine | |
GB2353240B (en) | Adjunct to a speed spanner | |
HK1046229A1 (en) | Method to form a mouthguard | |
AU3810500A (en) | Method for inducing viral resistance into a plant | |
AU2001274723A1 (en) | A method relating to copy protection | |
TW435423U (en) | Pacifier used as a decoration | |
GB9919279D0 (en) | Further improvements to can openers | |
GB0002601D0 (en) | Non obtrusive removeable solar panel attachment to headgear | |
GB0015824D0 (en) | A safe vaccine to prevent bacterial infections | |
GB9909072D0 (en) | Vaccine | |
GB9905867D0 (en) | A method of anion extraction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |